During the past decade, Indiana Univ. School of Medicine, Infectious Disease Research Clinic conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Indiana Univ. School of Medicine, Infectious Disease Research Clinic" #1 sponsor was "National Institute of Allergy and Infectious Diseases (NIAID)" with 89 trials, followed by "Glaxo Wellcome" with 4 trials sponsored, "Bristol-Myers Squibb" with 3 trials sponsored, "Janssen, LP" with 3 trials sponsored and "Abbott" with 3 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Indiana Univ. School of Medicine, Infectious Disease Research Clinic" #1 collaborator was "Glaxo Wellcome" with 7 trials as a collaborator, "Bristol-Myers Squibb" with 6 trials as a collaborator, "AIDS Clinical Trials Group" with 4 trials as a collaborator, "Schering-Plough" with 3 trials as a collaborator and "Amgen" with 2 trials as a collaborator. Other collaborators include 9 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "Indiana Univ. School of Medicine, Infectious Disease Research Clinic" are "HIV Infections" (105 trials), "Pneumonia, Pneumocystis Carinii" (8 trials), "Mycobacterium Avium-intracellulare Infection" (5 trials), "Hepatitis C" (4 trials) and "Histoplasmosis" (4 trials). Many other conditions were trialed in "Indiana Univ. School of Medicine, Infectious Disease Research Clinic" in a lesser frequency.

Most popular intervention types in "Indiana Univ. School of Medicine, Infectious Disease Research Clinic" are "Drug" (95 trials), "Biological" (6 trials), "Other" (3 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Zidovudine" (27 trials), "Didanosine" (19 trials), "Stavudine" (19 trials), "Lamivudine" (14 trials) and "Indinavir sulfate" (12 trials). Other intervention names were less common.

The vast majority of trials in "Indiana Univ. School of Medicine, Infectious Disease Research Clinic" are 105 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Indiana Univ. School of Medicine, Infectious Disease Research Clinic". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 103 completed trials in Indiana Univ. School of Medicine, Infectious Disease Research Clinic, 1 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Indiana Univ. School of Medicine, Infectious Disease Research Clinic, 9 "Phase 1" clinical trials were conducted, 46 "Phase 2" clinical trials and 24 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 19 trials that are defined as “Not Applicable".